You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
壽仙谷(603896.SH):康壽製藥收到藥品生產許可證 新增了水蜜丸、水丸兩個亞劑型及一條水蜜丸生產線
格隆匯 11-11 16:28

格隆匯11月11日丨壽仙谷(603896.SH)公佈,公司全資子公司金華市康壽製藥有限公司(“康壽製藥”)於近日收到浙江省藥品監督管理局頒發的《藥品生產許可證》(許可證編號:浙20150024),此次主要涉及新增生產範圍和生產線的變更,新增了水蜜丸、水丸兩個亞劑型及一條水蜜丸生產線。

此次《藥品生產許可證》新增生產範圍和生產線,為原温州温鶴金仙製藥有限公司的六味地黃丸變更到康壽製藥生產的必經程序,此次變更有利於六味地黃丸變更生產企業和生產地址。短期內對公司業績無重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account